In opioid case, NY wants to probe Teva's control of Teva USA
Teva Sells $15 Billion of Bonds - WSJ
Teva Reports Third Quarter 2020 Financial Results | Business Wire
Is Teva Pharmaceuticals a Brilliant Contrarian Pick? | The Motley Fool
Teva Pharmaceutical Industries Stock Is Estimated To Be Fairly Valued
Institutions Have Been Holding Back, but Teva Pharmaceutical Industries Limited (NYSE:TEVA) is Beginning to Stabilize
Does Teva Pharmaceutical Industries (NYSE:TEVA) Have A Healthy Balance Sheet? | Nasdaq
Teva Stock Offers Maximum Optimism For Investors (NYSE:TEVA) | Seeking Alpha
Why You Should Still Buy Teva (NYSE:TEVA) | Seeking Alpha
Teva Posts 2021 Earnings and Puts Opioid Litigation in Rearview Mirror | BioSpace
Teva Reports Fourth Quarter and Full Year 2019 Financial Results | Business Wire
Price-fixing lawsuit deals another blow to already fragile Teva, experts say | The Times of Israel
Teva earnings: Facing down cheaper generic prices, generic competition of its own and a lot of debt - MarketWatch
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
Teva Pharmaceutical Stock: Prepare For Takeoff (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical to sell assets such as women's health unit to cut debt | Mint
Israel's Teva pharmaceuticals keeps selling to Russia despite sanctions - The Jerusalem Post
Teva's (TEVA) Massive Debt Load Just Became an Even Bigger Issue - TheStreet
Teva Pharmaceutical or Mylan: Which Has the Better Debt Profile?
Should You Be Concerned About Teva Pharmaceutical Industries Limited's (NYSE:TEVA) ROE? | Nasdaq
Can Teva's Debt Repayment Plan Deleverage Its Balance Sheet?
Fitch downgrades Teva debt - Globes
